Table 1.
Patient Characteristics and Clinical Outcomes Versus Method of Lung Isolation
| Bronchial blocker (n = 17) | Main stem intubation (n = 15) | P | |
|---|---|---|---|
| Age, months (mean ± SD) | 10.4 ± 6.3 | 6.3 ± 4.4 | .06 |
| Gender (M:F) | 10:7 | 7:8 | .46 |
| Diagnoses | .50 | ||
| CPAM | 10 | 7 | |
| Bronchopulmonary sequestration | 5 | 6 | |
| Hybrid lesion | 1 | 1 | |
| Other | 1 | 1 | |
| Surgery time, minutes (mean ± SD) | 202.9 ± 73.5 | 139.3 ± 61.8 | .01 |
| Approach, n (%) | .47 | ||
| Thoracotomy | 0 (0) | 1 (6.7) | |
| Thoracoscopic | 17 (100) | 14 (93.3) | |
| CO2 insufflation used, n (%) | 13/17 (76.5) | 3/15 (20.0) | <.01 |
| ET CO2 after intubation, mmHg (mean ± SD) | 43.3 ± 8.5 | 41.4 ± 4.1 | .43 |
| Mean ET CO2 during surgery, mmHg (mean ± SD) | 52.5 ± 4.9 | 48.3 ± 5.6 | .03 |
| ET CO2 before extubation, mmHg (mean ± SD) | 45.7 ± 7.2 | 42.3 ± 2.7 | .09 |
| Anesthesia time, minutes (mean ± SD) | 328.9 ± 76.5 | 259.5 ± 72.1 | .02 |
| Estimated blood loss, mL (mean ± SD) | 47.1 ± 56.9 | 14.3 ± 12.5 | .04 |
| PRBC transfusion required, n (%) | 3/17 (17.7) | 0/15 (0) | .23 |
| Intraoperative complications, n (%) | 3/17 (17.7) | 0/15 (0) | .23 |
| Conversion to open, n (%) | 5/17 (29.4) | 1/14 (7.1) | .35 |
| Chest tube duration, days (mean ± SD) | 2.0 ± 1.1 | 2.3 ± 3.7 | .78 |
| Length of stay, days (mean ± SD) | 2.8 ± 2.0 | 3.3 ± 4.1 | .64 |
| Postoperative complications | 2 (11.8) | 0 (0) | .49 |
| Readmissions, n (%) | 1 (5.9) | 0 (0) | 1 |
| Repeat interventions, n (%) | 1 (5.9) | 0 (0) | 1 |
| Mortalities, n (%) | 0 (0) | 0 (0) | 1 |
CO2, carbon dioxide; CPAM, congenital pulmonary airway malformation; ET, end-tidal; F, female; M, male; PRBCs, packed red blood cells; SD, standard deviation.